JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Pfizer
PFE
|
+$919M |
| 3 |
Microsoft
MSFT
|
+$718M |
| 4 |
Wells Fargo
WFC
|
+$679M |
| 5 |
PepsiCo
PEP
|
+$641M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$1.62B |
| 2 |
Johnson & Johnson
JNJ
|
+$1.19B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$754M |
| 4 |
Booking.com
BKNG
|
+$726M |
| 5 |
SLB Ltd
SLB
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.26% |
| 2 | Healthcare | 11.26% |
| 3 | Technology | 10.53% |
| 4 | Consumer Discretionary | 8.07% |
| 5 | Industrials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IRC
3226
DELISTED
INLAND REAL ESTATE CORP
IRC
| $668K | ﹤0.01% |
62,463
-27,387
| -30% | -$300K |
|
|
PGRE
3227
DELISTED
Paramount Group
PGRE
| $666K | ﹤0.01% |
34,497
-1,024,057
| -97% | -$19.5M |
|
3228
United Bankshares
UBSI
$6.66B
| $666K | ﹤0.01% |
17,715
+8,240
| +87% | +$301K |
|
|
AEGN
3229
DELISTED
Aegion Corp
AEGN
| $664K | ﹤0.01% |
36,773
-1,600
| -4% | -$27.4K |
|
3230
PUT
Best Buy
BBY
$17.5B
| $663K | ﹤0.01% |
17,540
-26,800
| -60% | -$1.03M |
|
|
TRST
3231
Trustco Bank Corp NY
TRST
$963M
| $663K | ﹤0.01% |
19,270
-114
| -0.6% | -$3.86K |
|
3232
CALL
CVS Health
CVS
$121B
| $661K | ﹤0.01% |
6,400
-10,200
| -61% | -$1.03M |
|
|
LFC
3233
DELISTED
China Life Insurance Company Ltd.
LFC
| $660K | ﹤0.01% |
29,988
+912
| +3% | +$18.6K |
|
|
SYNT
3234
DELISTED
Syntel Inc
SYNT
| $658K | ﹤0.01% |
12,725
+7,923
| +165% | +$377K |
|
|
MPO
3235
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
| $658K | ﹤0.01% |
77,335
+4,622
| +6% | +$52.2K |
|
3236
Donaldson
DCI
$11.2B
| $656K | ﹤0.01% |
17,371
+4,145
| +31% | +$155K |
|
3237
Boston Beer
SAM
$1.89B
| $655K | ﹤0.01% |
2,452
+258
| +12% | +$74.8K |
|
|
MCP
3238
CALL
DELISTED
MOLYCORP INC COM STK
MCP
| $655K | ﹤0.01% |
+1,700,000
| New | +$1.1M |
|
3239
Medifast
MED
$130M
| $654K | ﹤0.01% |
21,830
-21,447
| -50% | -$681K |
|
3240
Stepan Co
SCL
$1.48B
| $653K | ﹤0.01% |
15,674
+300
| +2% | +$11.9K |
|
|
KFX
3241
DELISTED
KOFAX LIMITED COM STK
KFX
| $653K | ﹤0.01% |
+59,692
| New | +$437K |
|
3242
Tandem Diabetes Care
TNDM
$1.63B
| $649K | ﹤0.01% |
+5,140
| New | +$668K |
|
|
ATCO
3243
DELISTED
Atlas Corp.
ATCO
| $648K | ﹤0.01% |
35,500
| – | – |
|
3244
Emergent Biosolutions
EBS
$233M
| $647K | ﹤0.01% |
22,500
-200
| -0.9% | -$5.74K |
|
|
LORL
3245
DELISTED
Loral Space and Communications, Inc.
LORL
| $644K | ﹤0.01% |
9,417
-13
| -0.1% | -$939 |
|
3246
AeroVironment
AVAV
$9.81B
| $642K | ﹤0.01% |
24,235
+2,689
| +12% | +$71K |
|
|
NOAH
3247
Noah Holdings
NOAH
$588M
| $640K | ﹤0.01% |
27,372
-27,037
| -50% | -$567K |
|
|
UCB
3248
United Community Banks
UCB
$4.39B
| $638K | ﹤0.01% |
33,781
-1,800
| -5% | -$33.3K |
|
|
CLVS
3249
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $638K | ﹤0.01% |
8,600
-8,500
| -50% | -$600K |
|
3250
Pluri
PLUR
$17.6M
| $636K | ﹤0.01% |
2,839
+710
| +33% | +$167K |
|
Similar funds
JP Morgan Chase's Q1 2015 Portfolio in Review
As of Q1 2015, JP Morgan Chase held 4,553 positions worth $439B, up 0.39% from $437B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2015 filing shows 344 new, 1,711 increased, 1,692 reduced and 516 closed positions. Its largest new stake was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M. The largest sale was iShares MSCI EAFE ETF, an estimated $1.62B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q1 2015 buy was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2015 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.62B.
- JP Morgan Chase fully exited CAREFUSION CORPORATION in Q1 2015, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 16% of its $439B portfolio in Q1 2015.
- JP Morgan Chase opened 344 new positions and closed 516 in Q1 2015.
- JP Morgan Chase's portfolio value rose 0.39% quarter-over-quarter to $439B.
Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.